ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025
[Occurrence risk of extrahepatic liver tumor with hepatitis B virus infection].
Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Hepatitis B virus (HBV) infection is a global public health problem, which mainly causes a series of liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma. However, recent years' studies have shown that the occurrence of multiple extrahepatic malignancies may also be associated with HBV infection. For example, studies have found that patients with HBV infection have a significantly higher risk of developing digestive system tumors such as gastric cancer, colorectal cancer, and pancreatic cancer, as well as an increased risk of other systemic malignancies such as lymphoma, leukemia, and oral cancer. Although the liver is the primary target organ of HBV, the presence of the virus in non-hepatic tissues suggests that it may play an impact in the development of other extrahepatic tumors. The findings of these associations have important implications for public health policies and cancer prevention strategies, emphasizing the need for multisystem tumor screening in patients with HBV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.